Recent Updates
Recently added Catalysts
MYGN Positive Sentiment Score: 75/100

Myriad Genetics to Participate in Upcoming Healthcare Conferences

Thursday, February 9, 2023 1 min read
Key Takeaway: Myriad Genetics, Inc. (NASDAQ: MYGN) announced its participation in upcoming healthcare conferences, including the BTIG MedTech Conference on February 14, 2023, and the 44th Annual Raymond James & Associates Institutional Investors Conference on March 6, 2023. Additionally, the company will present at the 43rd Annual Cowen Health Care Conference on March 7, 2023. These conferences will highlight Myriad's advancements in genetic testing and precision medicine. Live webcasts of the presentations will be available on the company's website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Myriad Genetics is participating in major healthcare conferences, showcasing its leadership in the field.
  • The company is committed to advancing health through genetic testing and precision medicine.
  • Live presentations will provide valuable insights to investors and stakeholders.

Full Press Release Details

SALT LAKE CITY, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced management will participate at the upcoming healthcare conferences.
The BTIG MedTech, Digital Health, Life Sciences and Diagnostic Tools Conference on Feb. 14, 2023.
The 44th Annual Raymond James & Associates Institutional Investors Conference with a presentation on March 6, 2023, at 11:35 a.m. ET.
The 43rd Annual Cowen Health Care Conference with a presentation on March 7, 2023, at 10:30 a.m. ET.
The presentations at Raymond James and Cowen will be available through live audio webcast links in the investor information section of Myriad’s website at www.myriad.com.
About Myriad Genetics
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.
Media Contact: Investor Contact:
Glenn Farrell Matt Scalo
(801) 584-1153 (801) 584-3532
Glenn.Farrell@myriad.com Matt.Scalo@myriad.com

Frequently Asked Questions

What conferences will Myriad Genetics participate in?

Myriad Genetics will attend the BTIG Conference on Feb. 14, and the Raymond James and Cowen Conferences on March 6 and 7, 2023.

When is the Raymond James Conference presentation?

The Raymond James Conference presentation is scheduled for March 6, 2023, at 11:35 a.m. ET.

How can I access the conference presentations?

The presentations at the Raymond James and Cowen Conferences will be available via live audio webcasts on Myriad’s investor information page.

What does Myriad Genetics focus on?

Myriad Genetics specializes in genetic testing and precision medicine to enhance health and patient care.

Who to contact for media inquiries at Myriad?

For media inquiries, contact Glenn Farrell at (801) 584-1153 or Glenn.Farrell@myriad.com.

Tags: MYGN Viatris Investor Conferences Healthcare genetic testing precision medicine healthcare conferences Raymond James
Last updated: Feb 9, 2023